Large-scale analysis demonstrates the influence of CYP2C19 genotype on specific SSRI side effects
Chris Q. Eijsbouts, Yunxuan Jiang, James R. Ashenhurst, Julie M. Granka, Stella W. Aslibekyan, Robert K. Bell, Zayn Cochinwala, Sayantan Das, Kahsaia de Brito, Emily DelloRusso, Devika Dhamija, Payam Dibaeinia, Sarah L. Elson, Nicholas Eriksson, Shirin T. Fuller, , Rebekah Ryanne Wu
The paper analyzes the impact of CYP2C19 genotype on SSRI side effects and discontinuation rates in a large sample of individuals.
The Pharmacogenomics Journal · Aug 1, 2026Peer-reviewedGenetic & Genomic Medicine